Understand the source comparison
Best Peptides for Martial Arts: Performance Comparison
The table below compares peptide categories by their primary mechanism, martial arts-specific benefit, typical research dosing range, and key practical considerations. This is clinical reference data. Not personal recommendations. Ipamorelin Selective ghrelin
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares peptide categories by their primary mechanism, martial arts-specific benefit, typical research dosing range, and key practical considerations. This is clinical reference data. Not personal recommendations.
- Ipamorelin
- Selective ghrelin receptor agonist
- Accelerates systemic recovery without cortisol elevation
- 200–300 mcg 2–3x daily
- Short half-life requires multiple daily doses timed around training
- CJC-1295
- GHRH analogue with extended half-life
- Sustains baseline GH elevation for continuous tissue repair
- 1–2 mg weekly
- Synergizes with ghrelin agonists; avoid in active pituitary disorders
- BPC-157
- VEGF upregulation and NO pathway modulation
- Promotes tendon/ligament vascularization and collagen organization
- 250–500 mcg daily
- Most effective when administered near injury site; systemic effects still occur
- TB-500
- Actin polymerization and cell migration enhancement
- Reduces fibrotic scar tissue formation after joint injuries
- 2–5 mg weekly for 4–6 weeks
- Loading phase followed by maintenance; effects cumulative over weeks
- Cerebrolysin
- Neurotrophic factor delivery and BDNF upregulation
- Enhances motor learning speed and pattern retention under pressure
- 5–30 ml administered via deep IM injection
- Requires reconstitution; most research uses multi-week protocols
- Dihexa
- HGF pathway activation for synaptic density
- Improves reaction time and complex motor sequence execution
- Research doses vary widely; no standardized protocol
- Extremely potent neuroplastic effect; limited long-term human data